New drug combo may prevent dangerous ovarian condition in fertility patients
NCT ID NCT07568886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving albumin and furosemide right after egg retrieval can prevent severe ovarian hyperstimulation syndrome (OHSS) in women at high risk during ICSI. OHSS can cause swelling, fluid buildup, and sometimes hospitalization. The trial involved 200 women and compared the drug combination to standard care. The goal is to find a simple way to make fertility treatments safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- albumin and furosemide
- What this could lead to
- If effective, this combination could become a standard preventive treatment for ovarian hyperstimulation syndrome in high-risk women undergoing fertility treatments.
- What could go wrong
- This is a single completed trial with 200 participants. Results may not apply to all patients, and the combination may not reduce severe cases significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN HYPER STIMULATION SYNDROME (OHSS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
High Institute for Infertility Diagnosis and ART
Baghdad, Baghdad Governorate, 10006, Iraq